Terms: = Pancreatic cancer AND KLF4, EZF, 9314, ENSG00000136826, GKLF, O43474 AND Treatment
12 results:
1. Counterintuitive production of tumor-suppressive secretomes from Oct4- and c-Myc-overexpressing tumor cells and MSCs.
Li K; Sun X; Zha R; Liu S; Feng Y; Sano T; Aryal UK; Sudo A; Li BY; Yokota H
Theranostics; 2022; 12(7):3084-3103. PubMed ID: 35547745
[No Abstract] [Full Text] [Related]
2. Ethanol exposure of human pancreatic normal ductal epithelial cells induces EMT phenotype and enhances pancreatic cancer development in KC (Pdx1-Cre and LSL-Kras
Yu W; Ma Y; Roy SK; Srivastava R; Shankar S; Srivastava RK
J Cell Mol Med; 2022 Jan; 26(2):399-409. PubMed ID: 34859959
[TBL] [Abstract] [Full Text] [Related]
3. The low-complexity domains of the KMT2D protein regulate histone monomethylation transcription to facilitate pancreatic cancer progression.
Li W; Wu L; Jia H; Lin Z; Zhong R; Li Y; Jiang C; Liu S; Zhou X; Zhang E
Cell Mol Biol Lett; 2021 Nov; 26(1):45. PubMed ID: 34758724
[TBL] [Abstract] [Full Text] [Related]
4. MUC1-C dictates neuroendocrine lineage specification in pancreatic ductal adenocarcinomas.
Luan Z; Morimoto Y; Fushimi A; Yamashita N; Suo W; Bhattacharya A; Hagiwara M; Jin C; Kufe D
Carcinogenesis; 2022 Feb; 43(1):67-76. PubMed ID: 34657147
[TBL] [Abstract] [Full Text] [Related]
5. LRH-1 (liver receptor homolog-1) derived affinity peptide ligand to inhibit interactions between β-catenin and LRH-1 in pancreatic cancer cells: from computational design to experimental validation.
Pouraghajan K; Mahdiuni H; Ghobadi S; Khodarahmi R
J Biomol Struct Dyn; 2022 Apr; 40(7):3082-3097. PubMed ID: 33183172
[TBL] [Abstract] [Full Text] [Related]
6.
Ye S; Hu X; Ni C; Jin W; Xu Y; Chang L; Zhou H; Jiang J; Yang L
Mol Cancer Ther; 2020 Mar; 19(3):956-965. PubMed ID: 31924740
[TBL] [Abstract] [Full Text] [Related]
7. Glibenclamide Targets Sulfonylurea Receptor 1 to Inhibit p70S6K Activity and Upregulate klf4 Expression to Suppress Non-Small Cell Lung Carcinoma.
Xu K; Sun G; Li M; Chen H; Zhang Z; Qian X; Li P; Xu L; Huang W; Wang X
Mol Cancer Ther; 2019 Nov; 18(11):2085-2096. PubMed ID: 31341030
[TBL] [Abstract] [Full Text] [Related]
8. Inhibition of pancreatic cancer stem cell characteristics by α-Mangostin: Molecular mechanisms involving Sonic hedgehog and Nanog.
Ma Y; Yu W; Shrivastava A; Srivastava RK; Shankar S
J Cell Mol Med; 2019 Apr; 23(4):2719-2730. PubMed ID: 30712329
[TBL] [Abstract] [Full Text] [Related]
9. DNA-Methyltransferase 1 Induces Dedifferentiation of pancreatic cancer Cells through Silencing of Krüppel-Like Factor 4 Expression.
Xie VK; Li Z; Yan Y; Jia Z; Zuo X; Ju Z; Wang J; Du J; Xie D; Xie K; Wei D
Clin Cancer Res; 2017 Sep; 23(18):5585-5597. PubMed ID: 28659310
[No Abstract] [Full Text] [Related]
10. Evodiamine, a novel inhibitor of the Wnt pathway, inhibits the self-renewal of gastric cancer stem cells.
Wen Z; Feng S; Wei L; Wang Z; Hong D; Wang Q
Int J Mol Med; 2015 Dec; 36(6):1657-63. PubMed ID: 26497016
[TBL] [Abstract] [Full Text] [Related]
11. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs.
Wellner U; Schubert J; Burk UC; Schmalhofer O; Zhu F; Sonntag A; Waldvogel B; Vannier C; Darling D; zur Hausen A; Brunton VG; Morton J; Sansom O; Schüler J; Stemmler MP; Herzberger C; Hopt U; Keck T; Brabletz S; Brabletz T
Nat Cell Biol; 2009 Dec; 11(12):1487-95. PubMed ID: 19935649
[TBL] [Abstract] [Full Text] [Related]
12. 2-cyano-lup-1-en-3-oxo-20-oic acid, a cyano derivative of betulinic acid, activates peroxisome proliferator-activated receptor gamma in colon and pancreatic cancer cells.
Chintharlapalli S; Papineni S; Liu S; Jutooru I; Chadalapaka G; Cho SD; Murthy RS; You Y; Safe S
Carcinogenesis; 2007 Nov; 28(11):2337-46. PubMed ID: 17724373
[TBL] [Abstract] [Full Text] [Related]
